Jones, K.E.; Hayden, S.L.; Meyer, H.R.; Sandoz, J.L.; Arata, W.H.; Dufrene, K.; Ballaera, C.; Lopez Torres, Y.; Griffin, P.; Kaye, A.M.;
et al. The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations. Curr. Issues Mol. Biol. 2024, 46, 6315-6327.
https://doi.org/10.3390/cimb46070377
AMA Style
Jones KE, Hayden SL, Meyer HR, Sandoz JL, Arata WH, Dufrene K, Ballaera C, Lopez Torres Y, Griffin P, Kaye AM,
et al. The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations. Current Issues in Molecular Biology. 2024; 46(7):6315-6327.
https://doi.org/10.3390/cimb46070377
Chicago/Turabian Style
Jones, Kamryn E., Shaun L. Hayden, Hannah R. Meyer, Jillian L. Sandoz, William H. Arata, Kylie Dufrene, Corrado Ballaera, Yair Lopez Torres, Patricia Griffin, Adam M. Kaye,
and et al. 2024. "The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations" Current Issues in Molecular Biology 46, no. 7: 6315-6327.
https://doi.org/10.3390/cimb46070377
APA Style
Jones, K. E., Hayden, S. L., Meyer, H. R., Sandoz, J. L., Arata, W. H., Dufrene, K., Ballaera, C., Lopez Torres, Y., Griffin, P., Kaye, A. M., Shekoohi, S., & Kaye, A. D.
(2024). The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations. Current Issues in Molecular Biology, 46(7), 6315-6327.
https://doi.org/10.3390/cimb46070377
